Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281502
Max Phase: Preclinical
Molecular Formula: C21H16ClN5O2S
Molecular Weight: 437.91
Associated Items:
ID: ALA5281502
Max Phase: Preclinical
Molecular Formula: C21H16ClN5O2S
Molecular Weight: 437.91
Associated Items:
Canonical SMILES: COc1ccc2[nH]cc(-c3cc(/N=C4/NC(=O)CS4)n(-c4cccc(Cl)c4)n3)c2c1
Standard InChI: InChI=1S/C21H16ClN5O2S/c1-29-14-5-6-17-15(8-14)16(10-23-17)18-9-19(24-21-25-20(28)11-30-21)27(26-18)13-4-2-3-12(22)7-13/h2-10,23H,11H2,1H3,(H,24,25,28)
Standard InChI Key: TXMKVCJJUJONHS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 437.91 | Molecular Weight (Monoisotopic): 437.0713 | AlogP: 4.53 | #Rotatable Bonds: 4 |
Polar Surface Area: 84.30 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.88 | CX LogP: 4.54 | CX LogD: 4.31 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.49 | Np Likeness Score: -1.24 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):